Shoun H, Kim D-H, Uchiyama H, Sugiyama J
According to Langan et al
N=number of participants with measurement at the timepoint
Think of TDS mainly as a taste and mineral indicator, not a full safety test
Blue light from screens suppresses melatonin production and delays sleep onset
blood pressure remains controlled Medication Tolerability: Occasional early satiety reported, but no severe adverse events One-Year Visit Weight: Down 9 kg overall (BMI 31 kg/m), approaching his target of losing 1012 kg HbA1c: 6.9%, well within the personalized target range set by his endocrinologist Lifestyle: Continues brisk walking 34 times weekly and has enrolled in a weight management support group Quality of Life: Richard reports feeling more energetic, with fewer episodes of low blood sugar after the sulfonylurea dose adjustment Discussion and Alignment with Research Findings Long-Term Projection: Based on modeling data similar to the CORE diabetes model, semaglutide may offer substantial long-term benefits, including reduced risk of cardiovascular complications and improved survival (17)(18)
